San Carlos, CA, October 19, 2020 – FlemingMartin is pleased to announce that Natera (NASDAQ: NTRA), a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease, has hired Brittany Batte as Head of Companion Diagnostics Product Management.
Brittany will hold ownership of the product definition, strategic prioritization, technical product leadership, communication, and vision for Natera’s rapidly growing CDx business.
Brittany comes to Natera after six-and-a-half years with Myriad Genetics (NASDAQ: MYGN). In her most recent roles at Myriad, Brittany served as the Director of New Product Development and as a Product Manager for Companion Diagnostics. In these positions, Brittany directed strategic marketing, market development, and product lifecycle development activities for high-value molecular diagnostic products from discovery stage to commercialization. Prior to joining Myriad, Brittany served as a Genetic Counselor at the University of Texas’ MD Anderson Cancer Center.
Brittany received her Master of Science in Genetic Counseling from the University of Michigan and earned her Bachelor of Science in Biology from McMaster University in Hamilton, Ontario in Canada.
Natera is a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease. Natera’s Signatera technology is the first and only circulating tumor DNA (ctDNA) surveillance tool that detects molecular residual disease (MRD) for greater clinical confidence when assessing disease recurrence or treatment response in solid tumors. To learn more, visit natera.com.
FlemingMartin is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards, Private Equity Firms, and CEOs of companies to build successful execution-focused management teams. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital. flemingmartin.com